GNFT (GNFT) Stock Analysis
DELISTED 2026
What happened to GNFT (GNFT) stock?
GNFT (GNFT) no longer trades on public markets. It was delisted in January 2026. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- January 2026
- Last recorded price (historical):
- $8.95 (last quote on record before the January 2026 delisting; historical, not a current quote)
P/E 267.16 means the share price is 267.16 times one year of earnings per share. Market cap $446M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
GNFT (GNFT). Genfit S.A. is a biopharmaceutical company focused on developing innovative treatments for metabolic and liver diseases. With a robust pipeline, including drugs in various clinical trial phases, it aims to address significant unmet medical needs in its sector.
Last analyzed: Jun 13, 2026These figures come from statements filed 16 months ago — the most recent this company has published.
GNFT (GNFT) Healthcare & Pipeline Overview
GNFT ADR Information Sponsored
GNFT (GNFT) trades in the U.S. as an American Depositary Receipt (ADR).
- ADR Level: 2
- ADR Ratio: 1:1
More about this archive record
Can I still buy GNFT shares?
No. GNFT stopped trading on public markets in January 2026, so the shares are not available through a broker. Anything you see quoted for GNFT elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before GNFT stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to GNFT. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.